Insider Buying: ReWalk Robotics Ltd. (NASDAQ:LFWD) Director Purchases 6,000 Shares of Stock

ReWalk Robotics Ltd. (NASDAQ:LFWD) Director Joseph E. Turk, Jr. purchased 6,000 shares of the firm’s stock in a transaction on Friday, December 13th. The stock was bought at an average price of $1.69 per share, with a total value of $10,140.00. Following the completion of the purchase, the director now owns 18,516 shares of the company’s stock, valued at approximately $31,292.04. This represents a 47.94 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

ReWalk Robotics Trading Down 1.2 %

NASDAQ LFWD traded down $0.02 during midday trading on Tuesday, hitting $1.61. The company had a trading volume of 59,435 shares, compared to its average volume of 45,397. The company has a market capitalization of $14.18 million, a PE ratio of -0.65 and a beta of 2.04. The firm has a 50-day moving average price of $2.21 and a 200-day moving average price of $3.20. ReWalk Robotics Ltd. has a twelve month low of $1.51 and a twelve month high of $9.10.

ReWalk Robotics (NASDAQ:LFWD) last announced its quarterly earnings data on Tuesday, November 12th. The company reported ($0.35) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.08). The company had revenue of $6.13 million during the quarter, compared to analyst estimates of $8.38 million. ReWalk Robotics had a negative net margin of 77.21% and a negative return on equity of 43.02%. During the same period in the prior year, the firm earned ($0.56) earnings per share. On average, equities analysts anticipate that ReWalk Robotics Ltd. will post -1.78 EPS for the current year.

Hedge Funds Weigh In On ReWalk Robotics

An institutional investor recently bought a new position in ReWalk Robotics stock. Dimensional Fund Advisors LP bought a new position in ReWalk Robotics Ltd. (NASDAQ:LFWD) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 13,548 shares of the company’s stock, valued at approximately $54,000. Dimensional Fund Advisors LP owned approximately 0.16% of ReWalk Robotics as of its most recent SEC filing. 26.76% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, HC Wainwright restated a “buy” rating and issued a $13.00 price target on shares of ReWalk Robotics in a research note on Wednesday, November 13th.

ReWalk Robotics Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.